Enhancing gastric cancer conventional chemotherapy effects by triple angiokinase inhibitor nintedanib in preclinical models.

Awasthi, Niranjan; Schwarz, Margaret A; Kaurich, Quinn; Zhang, Changhua; Hilberg, Frank; Schwarz, Roderich E

Awasthi, Niranjan; Schwarz, Margaret A; Kaurich, Quinn; Zhang, Changhua; Hilberg, Frank; Schwarz, Roderich E.

Afiliación

Awasthi N; Department of Surgery, Indiana University School of Medicine, South Bend, IN, United States.
Schwarz MA; Harper Cancer Research Institute. University of Notre Dame, Notre Dame, IN, United States.
Kaurich Q; Harper Cancer Research Institute. University of Notre Dame, Notre Dame, IN, United States.
Zhang C; Department of Pediatrics, Indiana University School of Medicine, South Bend, IN, United States.
Hilberg F; Department of Surgery, Indiana University School of Medicine, South Bend, IN, United States.
Schwarz RE; Digestive Diseases Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.

Front Oncol ; 13: 1145999, 2023.

Article en En | MEDLINE | ID: mdl-37234980

Palabras clave

angiogenesis; chemotherapy; combination therapy; gastric cancer; nintedanib

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google